Astellas Pharma Total Liabilities 2012-2024 | ALPMY

Astellas Pharma total liabilities for the quarter ending June 30, 2024 were $13.178B, a 49.26% increase year-over-year.

  • Astellas Pharma total liabilities for 2024 were $13.07B, a 83.26% increase from 2023.
  • Astellas Pharma total liabilities for 2023 were $7.132B, a 0.22% decline from 2022.
  • Astellas Pharma total liabilities for 2022 were $7.148B, a 10.61% decline from 2021.

Astellas Pharma Total Liabilities 2012-2024 | ALPMY

  • Astellas Pharma total liabilities for 2024 were $13.07B, a 83.26% increase from 2023.
  • Astellas Pharma total liabilities for 2023 were $7.132B, a 0.22% decline from 2022.
  • Astellas Pharma total liabilities for 2022 were $7.148B, a 10.61% decline from 2021.